2-pyridinyl-6,7,8,9-tetrahydropyrimido(1 ,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyr imidin-5(1H)one derivatives

Details for Australian Patent Application No. 2002212249 (hide)

Owner Mitsubishi Pharma Corporation Sanofi-Aventis

Inventors Saady, Mourad; Li, Adrien Tak; Gallet, Thierry; Lochead, Alistair; Yaiche, Philippe; Almario Garcia, Antonio; Nedelec, Alain; Marguerie, Severine

Agent Davies Collison Cave

Pub. Number AU-B-2002212249

PCT Pub. Number WO02/18386

Priority 00402412 01.09.00 EP; 00402410 01.09.00 EP

Filing date 31 August 2001

Wipo publication date 13 March 2002

Acceptance publication date 30 November 2006

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

24 February 2005 Change of Name(s) of Applicant(s), Section 104

  Sanofi-Synthelabo The name of the applicant has been changed to Mitsubishi Pharma Corporation; Sanofi-Aventis

30 November 2006 Application Accepted

  Published as AU-B-2002212249

29 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002212250

2002212248-1-(alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7pyridinyl-imidazo(1,2-a)pyrimidin-5(1H)-one derivatives